Bz-DL-Arg-pNA · HCl

Bz-DL-Arg-pNA · HCl is a benzoyl-protected arginine derivative bearing a p-nitroanilide (pNA) leaving group, supplied as the hydrochloride salt. The molecule combines an N-benzoyl protecting group on the α-amino functionality with a side-chain guanidinium motif derived from arginine, enabling strong ionic interactions and controllable reactivity under peptide-coupling and enzymatic assay conditions. The p-nitroanilide chromophore provides a measurable reporter for amide cleavage, while the salt form improves handling and solubility for analytical and screening workflows. The DL stereochemical designation indicates racemic composition at the α-carbon, making the compound suitable as a chiral-insensitive substrate or reagent for method development and intermediate preparation where stereochemical discrimination is not required.

1. Enzyme Activity Assays

Bz-DL-Arg-pNA · HCl is applied in enzymology and biochemical research as a chromogenic substrate for protease activity measurements. The arginine-derived guanidinium side chain and the amide-linked p-nitroanilide reporter allow cleavage events to be monitored through changes in pNA absorbance, while the N-benzoyl group can modulate access to the scissile bond. Hydrochloride salt formation supports reproducible assay preparation by maintaining the guanidinium functionality in a protonated state. The resulting readout supports substrate profiling, inhibitor screening, and method optimization in studies of arginine-recognizing proteases and related catalytic systems.

2. Protease Inhibitor Screening

Bz-DL-Arg-pNA · HCl is used in drug discovery and chemical biology workflows to evaluate candidate inhibitors targeting arginine-specific proteolysis. The compound's arginine side-chain architecture and pNA leaving group create a direct structure-to-signal relationship for competitive or mechanism-dependent inhibition readouts. The benzoyl-protected N-terminus provides a defined acyl environment that can be incorporated into SAR studies by comparing inhibitor effects across substrate analogs. Downstream, assay results can guide selection of peptidomimetic scaffolds and inform medicinal chemistry decisions for compounds designed to engage guanidinium recognition elements.

3. Peptidomimetic Building Blocks

Bz-DL-Arg-pNA · HCl serves as a reagent for constructing arginine-based peptidomimetic fragments and for generating protected arginine-related intermediates. The protected α-amino functionality (benzoyl) and the guanidinium-bearing side chain enable synthetic elaboration toward amide-linked motifs, while the pNA group can be used as a functional handle for transformation into alternative leaving groups or reporter-free analogs. Racemic stereochemistry at the α-carbon supports scalable synthesis where stereochemical purity is not a prerequisite for downstream library generation. The compound therefore supports fragment assembly and iterative derivatization in synthetic organic chemistry and peptide analog development.

4. Analytical Method Development

Bz-DL-Arg-pNA · HCl is suitable for analytical research focused on developing and validating protease assay conditions and detection workflows. The p-nitroanilide chromophore provides a convenient spectroscopic endpoint, and the arginine guanidinium functionality supports selective substrate recognition by enzymes that favor basic residues. The hydrochloride salt form can improve reproducibility in buffer preparation by stabilizing protonation states relevant to binding and cleavage. The compound can be employed to establish calibration behavior, compare substrate lots, and support routine quality control of enzymatic assay reagents used in screening laboratories.

5. Process Chemistry Intermediate Use

Bz-DL-Arg-pNA · HCl can be incorporated into industrially oriented process chemistry as an intermediate for preparing arginine-derived amide substrates and related fine chemicals. The presence of a stable N-benzoyl protecting group and a guanidinium-containing side chain allows controlled downstream transformations that maintain the key functional pattern required for substrate-like structures. The pNA moiety supports straightforward monitoring of cleavage or conversion during method development, which can translate into practical manufacturing route design for assay-grade reagents. The compound's defined functional group set aligns with scalable synthesis of protected amino acid derivatives and related screening reagents used in applied chemical manufacturing environments.

1. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

2. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

4. The spatiotemporal control of signalling and trafficking of the GLP-1R

5. TMEM16F and dynamins control expansive plasma membrane reservoirs